BioCryst Pharmaceuticals, Inc.
BCRX
$8.39
-$0.17-1.99%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -11.88% | -8.03% | -2.78% | 21.32% | -19.17% |
Total Receivables | -2.37% | 18.12% | 9.13% | 5.38% | 13.49% |
Inventory | -26.61% | -15.01% | 6.94% | 69.93% | -85.06% |
Prepaid Expenses | -12.47% | 4.18% | -15.53% | -0.88% | -10.64% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 10,093.13% | 38.57% | -74.17% | -54.71% | -0.17% |
Total Current Assets | -2.81% | -2.84% | -1.21% | 17.52% | -18.71% |
|
|||||
Total Current Assets | -2.81% | -2.84% | -1.21% | 17.52% | -18.71% |
Net Property, Plant & Equipment | 2.19% | -1.06% | 0.78% | -1.11% | -4.16% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -4.42% | 5.66% | 13.05% | 1.12% | 31,284.81% |
Total Assets | -4.76% | -2.12% | -0.17% | 3.99% | 0.97% |
|
|||||
Total Accounts Payable | -14.53% | -13.70% | -13.63% | 73.16% | -34.63% |
Total Accrued Expenses | 15.63% | -18.23% | 8.73% | 16.29% | 13.06% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.55% | 4.86% | -1.23% | 13.28% | 10.15% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 26.67% | -12.80% | 4.44% | 18.98% | 7.63% |
|
|||||
Total Current Liabilities | 26.67% | -12.80% | 4.44% | 18.98% | 7.63% |
Long-Term Debt | -11.69% | -1.75% | -0.02% | -1.53% | -0.56% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 4.35% | 0.45% | -0.93% | -3.22% | -5.61% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -5.71% | -3.56% | 0.68% | 1.24% | 0.42% |
|
|||||
Common Stock & APIC | 1.88% | 1.84% | 1.63% | 1.54% | 1.08% |
Retained Earnings | 0.29% | 0.00% | -1.54% | -0.81% | -0.74% |
Treasury Stock & Other | 45.41% | 22.91% | -59.83% | 311.67% | -27.76% |
Total Common Equity | 6.71% | 5.04% | -1.57% | 1.48% | 0.12% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 6.71% | 5.04% | -1.57% | 1.48% | 0.12% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 6.71% | 5.04% | -1.57% | 1.48% | 0.12% |
|